A ranar 12 ga Maris, 2022, NMPA (SFDA) ta ba da sanarwar amincewa da canjin aikace-aikacen don gwajin kai na samfuran antigen COVID-19 ta Nanjing Vazyme Biotech Co., Ltd, Beijing Jinwofu Bioengineering Technology Co., Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Guangzhou Wondfo B...
Kara karantawa